Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 8 | 2021 | 563 | 1.530 |
Why?
|
| Cell Proliferation | 6 | 2018 | 2554 | 0.770 |
Why?
|
| Interferon-gamma | 3 | 2020 | 538 | 0.640 |
Why?
|
| Cell Differentiation | 4 | 2016 | 2025 | 0.640 |
Why?
|
| Bromodeoxyuridine | 1 | 2018 | 59 | 0.570 |
Why?
|
| Uveal Neoplasms | 3 | 2013 | 60 | 0.570 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2016 | 31 | 0.530 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2013 | 65 | 0.520 |
Why?
|
| Flow Cytometry | 1 | 2018 | 836 | 0.480 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2013 | 509 | 0.430 |
Why?
|
| Melanocytes | 1 | 2013 | 48 | 0.420 |
Why?
|
| Melanoma | 3 | 2013 | 964 | 0.350 |
Why?
|
| Hematopoiesis | 3 | 2021 | 230 | 0.330 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2021 | 160 | 0.310 |
Why?
|
| Cell Cycle | 3 | 2018 | 626 | 0.220 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2020 | 11 | 0.170 |
Why?
|
| Busulfan | 1 | 2020 | 45 | 0.170 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2020 | 26 | 0.170 |
Why?
|
| Cell Division | 2 | 2020 | 773 | 0.170 |
Why?
|
| Antigens, CD | 1 | 2020 | 452 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 432 | 0.150 |
Why?
|
| Bone Marrow | 2 | 2020 | 335 | 0.150 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 273 | 0.140 |
Why?
|
| Cell Lineage | 2 | 2020 | 369 | 0.140 |
Why?
|
| Mycobacterium avium | 1 | 2016 | 16 | 0.130 |
Why?
|
| Mice | 8 | 2021 | 18935 | 0.130 |
Why?
|
| Cell Self Renewal | 1 | 2016 | 50 | 0.130 |
Why?
|
| Animals | 10 | 2021 | 36412 | 0.130 |
Why?
|
| RNA Interference | 3 | 2013 | 545 | 0.130 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 25 | 0.120 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 39 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 65 | 0.120 |
Why?
|
| Bone Marrow Diseases | 1 | 2016 | 41 | 0.120 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 62 | 0.120 |
Why?
|
| Zinc Fingers | 1 | 2016 | 124 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 149 | 0.120 |
Why?
|
| Thrombocythemia, Essential | 1 | 2015 | 30 | 0.120 |
Why?
|
| Polycythemia Vera | 1 | 2015 | 39 | 0.120 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 102 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 49 | 0.110 |
Why?
|
| Hydroxyurea | 1 | 2015 | 86 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2014 | 123 | 0.110 |
Why?
|
| Host Cell Factor C1 | 1 | 2013 | 11 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2016 | 537 | 0.110 |
Why?
|
| Interferon-alpha | 1 | 2015 | 248 | 0.100 |
Why?
|
| Homeostasis | 1 | 2018 | 746 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2016 | 4907 | 0.100 |
Why?
|
| Heterografts | 1 | 2013 | 199 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2013 | 3754 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2013 | 439 | 0.100 |
Why?
|
| Protein Binding | 2 | 2013 | 1844 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 92 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 352 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 1190 | 0.090 |
Why?
|
| Retinoblastoma Protein | 1 | 2010 | 86 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 129 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 92 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 644 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4838 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 746 | 0.070 |
Why?
|
| Gammaherpesvirinae | 1 | 2007 | 6 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 3030 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 4790 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1920 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2007 | 344 | 0.060 |
Why?
|
| Humans | 9 | 2020 | 133552 | 0.060 |
Why?
|
| DNA Damage | 1 | 2007 | 545 | 0.050 |
Why?
|
| Apoptosis | 1 | 2010 | 1928 | 0.050 |
Why?
|
| Phenotype | 1 | 2013 | 4553 | 0.050 |
Why?
|
| Histones | 1 | 2007 | 568 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 1411 | 0.050 |
Why?
|
| Mutation | 2 | 2021 | 6292 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1850 | 0.050 |
Why?
|
| E-Selectin | 1 | 2020 | 43 | 0.040 |
Why?
|
| Radiation Chimera | 1 | 2020 | 18 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 37 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 106 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2020 | 141 | 0.040 |
Why?
|
| Clone Cells | 1 | 2020 | 180 | 0.040 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 2 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2016 | 12 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 248 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2016 | 342 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2527 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2010 | 1707 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 395 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 132 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 777 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2016 | 309 | 0.030 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2011 | 13 | 0.020 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2011 | 34 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2011 | 65 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1616 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 318 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2011 | 168 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 257 | 0.020 |
Why?
|
| Male | 2 | 2015 | 65790 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2010 | 52 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 396 | 0.020 |
Why?
|
| Indoles | 1 | 2011 | 202 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 100 | 0.020 |
Why?
|
| Etoposide | 1 | 2010 | 120 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2010 | 144 | 0.020 |
Why?
|
| E2F1 Transcription Factor | 1 | 2010 | 51 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2010 | 67 | 0.020 |
Why?
|
| Purines | 1 | 2010 | 119 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 613 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 959 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 317 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 110 | 0.020 |
Why?
|
| Serine | 1 | 2010 | 185 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2010 | 199 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2805 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 786 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 701 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 1006 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 369 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3989 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2010 | 664 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2007 | 220 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2654 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 1535 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 2007 | 147 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 526 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 3429 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 5076 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 791 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2010 | 931 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 610 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2007 | 360 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2007 | 456 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 6577 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 1833 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2007 | 674 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2899 | 0.010 |
Why?
|
| Virus Replication | 1 | 2007 | 637 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 21640 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 29262 | 0.010 |
Why?
|
| Female | 1 | 2015 | 71541 | 0.000 |
Why?
|